Featured Research

from universities, journals, and other organizations

Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis

Date:
September 6, 2012
Source:
American Society of Nephrology (ASN)
Summary:
• Blood tests of particular autoantibodies can accurately diagnose the autoimmune kidney disease called idiopathic membranous nephropathy. • Patients with high levels of these autoantibodies tend to have more severe disease, while those with low levels often experience remission. Each year, an estimated 50,000 people globally are diagnosed with idiopathic membranous nephropathy.

Simple blood tests could help physicians decide which patients with a particular autoimmune kidney disease can forgo potentially toxic medications and which need to be treated, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

Idiopathic membranous nephropathy is an autoimmune kidney disease that leads to kidney failure in at least half of patients if left untreated. Immunosuppressive therapy is effective, but toxic. "It is unclear who should be treated, when treatment should be started, and how long treatment should be continued. We need better tools to aid decision-making," said Julia Hofstra, MD, PhD (Radboud University Nijmegen Medical Center, in The Netherlands).

Researchers have recently identified antibodies -- called antiPLA2R autoantibodies -- that form and damage the kidneys when the disease develops. Clinicians do not have a standard technique for measuring these autoantibodies nor do they know whether autoantibody levels provide any information about the severity of patients' disease.

Hofstra, in collaboration with Hanna Debiec, PhD (Institut National de la Santé et de la Recherche Médicale, in France), Paul Brenchley, PhD (University of Manchester, in the United Kingdom), and others compared two different blood tests (called IIFT and ELISA) to measure antiPLA2R autoantibodies in 117 patients with idiopathic membranous nephropathy.

Among the major findings:

  • 74% of patients tested positive for antiPLA2R antibodies by IIFT and 72% tested positive by ELISA.
  • Concordance between both tests was excellent, with 94% agreement.
  • Antibody levels significantly correlated with the severity of patients' disease.
  • Spontaneous remissions occurred much less frequently among patients with high antibody levels (38% versus 4% in the lowest and highest groups, respectively).

The findings reveal high agreement between IIFT and ELISA measurements of antiPLA2R antibody levels and highlight the important role of these antibodies in idiopathic membranous nephropathy, given the relationships between antiPLA2R levels, disease severity, and remission rates.

"The data provide hope that in the near future, antiPLA2R antibodies can be detected with a simple assay and measuring the antibody levels may improve optimal treatment in patients with idiopathic membranous nephropathy," said Dr. Hofstra.

Study co-authors include Colin Short, MD, FRCP, Timotheé Pellé, Robert Kleta, MD, PhD, Peter Mathieson, PhD, FRCP, Pierre Ronco, MD, PhD, and Jack Wetzels, MD, PhD.


Story Source:

The above story is based on materials provided by American Society of Nephrology (ASN). Note: Materials may be edited for content and length.


Journal Reference:

  1. Julia M. Hofstra, Hanna Debiec, Colin D. Short, Timotheé Pellé, Robert Kleta, Peter W. Mathieson, Pierre Ronco, Paul E. Brenchley, and Jack F. Wetzels. Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy. Journal of the American Society of Nephrology, 2012; DOI: 10.1681/ASN.2012030242

Cite This Page:

American Society of Nephrology (ASN). "Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis." ScienceDaily. ScienceDaily, 6 September 2012. <www.sciencedaily.com/releases/2012/09/120906181636.htm>.
American Society of Nephrology (ASN). (2012, September 6). Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/09/120906181636.htm
American Society of Nephrology (ASN). "Simple Blood Tests Detect Autoimmune Kidney Disease, Help Predict Prognosis." ScienceDaily. www.sciencedaily.com/releases/2012/09/120906181636.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins